Comparison between Aelea Commodities IPO and Ambey Laboratories IPO.
Aelea Commodities IPO is a SME Bookbuilding IPO proposed to list at BSE SME while Ambey Laboratories IPO is a SME Bookbuilding proposed to list at NSE SME.
| Aelea Commodities IPO | Ambey Laboratories IPO | |
|---|---|---|
| Logo |  |  |
| Issue Category | SME | SME |
| Issue Type | IPO | IPO |
| Process Type | Bookbuilding | Bookbuilding |
| Listing At | BSE SME | NSE SME |
| Lead Managers | Ekadrisht Capital Pvt.Ltd. | Novus Capital Advisors Private Limited |
| Registrar | Maashitla Securities Pvt.Ltd. | MUFG Intime India Pvt.Ltd. |
| Market Maker | SS Corporate Securities Ltd. | Nikunj Stock Brokers Ltd. |
| DRHP | DRHP  | DRHP |
| RHP | RHP | RHP |
| Final Prospectus | Final Prospectus | Final Prospectus |
| Anchor Investor | Anchor Investor | Anchor Investor |
| IPO Allotment URL | IPO Allotment URL | IPO Allotment URL |
The total issue size of Aelea Commodities IPO is up to ₹48.45 Cr whereas the issue size of the Ambey Laboratories IPO is up to ₹42.43 Cr. The final issue price of Aelea Commodities IPO is ₹95.00 per share and of Ambey Laboratories IPO is ₹68.00 per share.
| Aelea Commodities IPO | Ambey Laboratories IPO | |
|---|---|---|
| Face Value | ₹10 per share | ₹10 per share |
| Issue Price (Lower) | ₹91.00 per share | ₹65.00 per share |
| Issue Price (Upper) | ₹95.00 per share | ₹68.00 per share |
| Issue Price (Final) | ₹95.00 per share | ₹68.00 per share |
| Discount (Retail) | ₹0.00 per share | ₹0.00 per share |
| Discount (Employee) | ||
| Market Lot Size | 1200 shares | 2000 shares |
| Fresh Issue Size | 51,00,000 shares | 59,28,000 shares |
| Fresh Issue Size (Amount) | up to ₹48.45 Cr | up to ₹40.31 Cr |
| OFS Issue Size | 0 shares | 3,12,000 shares |
| OFS Issue Size (Amount) | up to ₹0.00 Cr | up to ₹2.12 Cr |
| Issue Size Total | 51,00,000 shares | 62,40,000 shares |
| Issue Size Total (Amount) | up to ₹48.45 Cr | up to ₹42.43 Cr |
Aelea Commodities IPO opens on Jul 12, 2024, while Ambey Laboratories IPO opens on Jul 04, 2024. The closing date of Aelea Commodities IPO and Ambey Laboratories IPO is Jul 16, 2024, and Jul 08, 2024, respectively.
| Aelea Commodities IPO | Ambey Laboratories IPO | |
|---|---|---|
| Anchor Bid Date | Jul 11, 2024 | Jul 03, 2024 |
| Issue Open | Jul 12, 2024 | Jul 04, 2024 |
| Issue Close | Jul 16, 2024 | Jul 08, 2024 |
| Basis Of Allotment (Tentative) | Jul 18, 2024 | Jul 09, 2024 |
| Initiation of Refunds (Tentative) | Jul 19, 2024 | Jul 10, 2024 |
| Credit of Share (Tentative) | Jul 19, 2024 | Jul 10, 2024 |
| Listing date (Tentative) | Jul 22, 2024 | Jul 11, 2024 |
| Anchor Lockin End date 1 | Aug 17, 2024 | Aug 08, 2024 |
| Anchor Lockin End date 2 | Oct 16, 2024 | Oct 07, 2024 |
Aelea Commodities IPO P/E ratio is 11.62, as compared to Ambey Laboratories IPO P/E ratio of 27.81.
| Aelea Commodities IPO | Ambey Laboratories IPO | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Financials | Company Financials (Restated Consolidated)
| Company Financials (Restated)
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Promoter Shareholding (Pre-Issue) | 86.45 | 94.97 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Promoter Shareholding (Post-Issue) | 63.66 | 69.9 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| P/E Ratio | 11.62 | 27.81 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Market Cap | ₹193.03 Cr. | ₹171.64 Cr. | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ROE | 5.92% | 20.80% | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ROCE | 5.72% | 13.14% | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Debt/Equity | 0.85 | 0.58 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| EPS | ₹8.18 | ₹2.44 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| RoNW | 5.75% | 20.80% | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
In the Aelea Commodities IPO Retail Individual Investors (RII) are offered 17,85,600 shares while in Ambey Laboratories IPO retail investors are offered 17,85,600 shares. Qualified Institutional Buyers (QIB) are offered 10,20,000 shares in Aelea Commodities IPO and 12,48,000 shares in Ambey Laboratories IPO.
| Aelea Commodities IPO | Ambey Laboratories IPO | |
|---|---|---|
| Anchor Investor Reservation | 15,28,800 shares | 18,72,000 shares |
| Market Maker Reservation | 2,68,800 shares | 3,30,000 shares |
| QIB | 10,20,000 shares | 12,48,000 shares |
| NII | 7,65,600 shares | 9,36,000 shares |
| RII | 17,85,600 shares | 21,84,000 shares |
| Employee | ||
| Others | ||
| Total | 51,00,000 shares | 62,40,000 shares |
Aelea Commodities IPO subscribed 195.83x in total, whereas Ambey Laboratories IPO subscribed 173.18x.
| Aelea Commodities IPO | Ambey Laboratories IPO | |
|---|---|---|
| QIB (times) | 104.22x | 61.90x |
| NII (times) | 389.87x | 324.22x |
| Big NII (times) | ||
| Small NII (times) | ||
| RII (times) | 164.95x | 195.06x |
| Employee (times) | ||
| Other (times) | ||
| Total (times) | 195.83x | 173.18x |
